NCT04326595

Brief Summary

  1. 1.To evaluate histopathological findings of products of conception in both sporadic and recurrent miscarriage.
  2. 2.To determine the prevalence of chronic histiocytic intervillositis in both sporadic and recurrent miscarriage.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 30, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

December 20, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

1 year

First QC Date

March 25, 2020

Last Update Submit

March 27, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • percentage of results of products of conception assessed by histopathological evaluation

    to asses the result of analysis of products of abortion and divide them into groups according to the results and asses percentage of each type types predicted :1-products of conception 2-no products of conception 3-partial moel 4-complete mole 5-Arias-stella reaction 6-others

    one year

Secondary Outcomes (1)

  • rate of participants show chronic histiocytic intervillositis in histopathological evaluation

    one year

Study Arms (2)

surgical termination

ACTIVE COMPARATOR
Procedure: surgical and medical evacuation

medical termination

ACTIVE COMPARATOR
Procedure: surgical and medical evacuation

Interventions

surgical evacuation:the dilation of the cervix and surgical evacuation of the uterus (potentially including the fetus, placenta and other tissue) medical evacuation: induction of abortion by the use of ecbolics

medical terminationsurgical termination

Eligibility Criteria

Age17 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll of the patients had vaginal bleeding and pelvic pain. After vaginal examination , transvaginal ultrasonography findings and serum β-HCG levels were performed to verify the diagnosis. The cases were classified as complete, incomplete, missed, or anembryonic miscarriage according to the guidelines of the Royal College of Obstetrics and Gynecology (RCOG) on the basis of transvaginal ultrasonography\[5\]. Missed miscarriage was defined as the presence of a non-viable fetus. An intact gestational sac with an absence of fetal echo was diagnosed as an anembryonic miscarriage. Incomplete miscarriage was defined as the presence of heterogeneous tissues (with or without a gestational sac) distorting the endometrial midline echo by transvaginal ultrasonography.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • all pregnants with clinical symptoms and signs of abortion
  • fit for medical induction of abortion
  • fit for surgical procedure

You may not qualify if:

  • threatened abortion
  • complete abortion
  • unfit participants for medical abortion
  • unfit participants for surgical procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Poland BJ, Miller JR, Jones DC, Trimble BK. Reproductive counseling in patients who have had a spontaneous abortion. Am J Obstet Gynecol. 1977 Apr 1;127(7):685-91. doi: 10.1016/0002-9378(77)90240-x.

    PMID: 848521BACKGROUND
  • WARBURTON D, FRASER FC. SPONTANEOUS ABORTION RISKS IN MAN: DATA FROM REPRODUCTIVE HISTORIES COLLECTED IN A MEDICAL GENETICS UNIT. Am J Hum Genet. 1964 Mar;16(1):1-25. No abstract available.

    PMID: 14131871BACKGROUND
  • Doubilet PM, Benson CB, Bourne T, Blaivas M; Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy; Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter MB, Pretorius DH, Timor-Tritsch IE. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med. 2013 Oct 10;369(15):1443-51. doi: 10.1056/NEJMra1302417. No abstract available.

    PMID: 24106937BACKGROUND
  • Lemmers M, Verschoor MAC, Bossuyt PM, Huirne JAF, Spinder T, Nieboer TE, Bongers MY, Janssen IAH, Van Hooff MHA, Mol BWJ, Ankum WM, Bosmans JE; MisoREST study group. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study. Acta Obstet Gynecol Scand. 2018 Mar;97(3):294-300. doi: 10.1111/aogs.13283. Epub 2018 Jan 19.

    PMID: 29266169BACKGROUND
  • Luise C, Jermy K, May C, Costello G, Collins WP, Bourne TH. Outcome of expectant management of spontaneous first trimester miscarriage: observational study. BMJ. 2002 Apr 13;324(7342):873-5. doi: 10.1136/bmj.324.7342.873.

    PMID: 11950733BACKGROUND

MeSH Terms

Conditions

Abortion, Habitual

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Abortion, SpontaneousPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

mohammed haggag hashim, resident

CONTACT

Tarek khalaf Al-Hussaini, prof.dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: 1. Full detailed history taking . 2. Through clinical examination . 3. pregnancy was confirmed by ultrasound examination or serum beta human chorionic gonadotropins (β-HCG) level for patients. 4. All patients had routine laboratory tests including blood group, Rh factor, complete blood count, and electrolytes. 5. Then the all tissues obtained at evacuation should be submitted for histopathological examination
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 25, 2020

First Posted

March 30, 2020

Study Start

December 20, 2020

Primary Completion

December 30, 2021

Study Completion

May 30, 2022

Last Updated

March 31, 2020

Record last verified: 2020-03